Connect clinical sources
Bring approved clinical study reports, protocols, summaries, and relevant datasets into a traceable authoring workflow.
NARRATIVA · REGULATORY
Clinical Overview Automation with AI Agents
Bring clinical pharmacology, efficacy, and safety evidence into a structured Clinical Overview—with source-aware drafting and expert-led critical assessment for CTD Module 2.5.
AI AGENTS TRUSTED BY LIFE SCIENCES ORGANIZATIONS
CLINICAL OVERVIEW · COORDINATED AI AGENTS
Synthesize. Assess.
Tell the clinical story.
Purpose-built agents help teams bring clinical evidence into a clear, structured narrative, compare findings across studies, and prepare content for critical review by clinical and regulatory experts.
Frame the development program
Organize study designs, patient populations, treatment exposure, and program context to orient the clinical narrative.
Summarize clinical pharmacology
Bring pharmacokinetics, pharmacodynamics, dose rationale, and relevant special-population evidence into context.
Synthesize efficacy evidence
Summarize key endpoints and findings across relevant trials, with attention to consistency, limitations, and clinical context.
Assess the safety profile
Organize adverse-event findings, important risks, and exposure context for a balanced clinical safety narrative.
Integrate and quality-check
Assemble a coherent CTD Module 2.5 draft with references, consistency checks, and clinical expert review.
MEDICAL AUTHORING COMPANION · CLINICAL DEVELOPMENT
Tell the clinical story across the development program.
The Clinical Overview is CTD Module 2.5: a concise, critical assessment of the clinical data in a marketing application. It describes the clinical development program, summarizes relevant clinical pharmacology, efficacy, and safety findings, and discusses how the evidence supports the proposed product information and benefit–risk profile.
Medical Authoring Companion helps teams organize source evidence and prepare structured drafts that connect narrative statements to their supporting materials. Clinical and regulatory experts remain responsible for interpretation, critical assessment, conclusions, and approval against the applicable regional requirements.
CLINICAL OVERVIEW · FAQ
Clinical evidence, clearly connected.
Learn how AI-assisted authoring can support a critical, source-grounded overview of clinical data.
What is the Clinical Overview?
The Clinical Overview is CTD Module 2.5, a concise critical assessment of the clinical data in a marketing application. It summarizes the development program and the key clinical pharmacology, efficacy, and safety evidence, placing the findings in context for the application.
How can AI agents help prepare a Clinical Overview?
Agents can help gather and organize approved sources, structure sections, prepare evidence-grounded summaries, and support consistency and reference checks. Clinical and regulatory experts direct the work and perform the critical assessment.
Which evidence can inform the document?
Teams may use clinical study reports, protocols, clinical pharmacology reports, integrated summaries, datasets, and other approved application materials as appropriate. Source selection is defined by the application and organization’s procedures.
How are efficacy and safety findings brought together?
A structured workflow can organize findings by clinical domain and study, connect summaries to supporting evidence, and help reviewers compare results across the program. Expert authors interpret the totality of evidence and its relevance to the proposed use.
Can AI determine the benefit–risk conclusion?
No. AI can support evidence organization and drafting, but qualified clinical and regulatory experts make the critical assessment and are responsible for benefit–risk conclusions and the application narrative.
How is traceability supported?
Source references can connect draft statements to underlying documents or data, helping reviewers verify support, identify gaps, and manage revisions. Final quality review follows the sponsor’s procedures and applicable submission requirements.